No Data
No Data
Haemonetics (HAE) Is a Top-Ranked Value Stock: Should You Buy?
Zacks.com Featured Highlights Include Skechers, Walmart, Haemonetics, AZZ and BOK Financial
Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation
DaVita (DVA) Gains 36% YTD: What's Driving the Stock Rally?
Buy 5 Stocks With Upgraded Broker Ratings for Robust Returns
Haemonetics Shares Rise After Upgrade From Needham
Haemonetics (HAE) shares were up 3.5% in recent Wednesday trading after Needham upgraded the stock to buy from hold with a price target of $112. Trading volume stood at about 768,000 shares against a
No Data